LYRICA 225 MG CAPSULE

PREGABALIN
$9.6742per EA
High Outlier
DEA Schedule CV

Strength

225 mg/1

Manufacturer

Pfizer Inc.

NDC

00071101968

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PREGABALIN

Approval Type

New Drug (NDA)

FDA Application

NDA021446

On Market Since

12/30/2004

Price History

1W

0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.4%

3Y

+4.5%

5Y

+17.1%

All

+169.2%

Related Drugs

Same classification

No related drugs found.